Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Anticancer Research
|
September 16, 2016
A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab
Alina Basnet, Nibal Saad, Sam Benjamin
Radiology Case Reports
|
January 31, 2024
Hepatocellular carcinoma metastatic to the pituitary gland without an identifiable primary lesion
Jacquelyn Knapp, Harish Babu, Sam Benjamin, et al.
Cureus
|
August 9, 2020
Mucosal Melanoma: A Rare Entity and Review of the Literature
Raman J Sohal, Sandeep Sohal, Ali Wazir, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-Analysis
Susu Zhou, Devashish Desai, Sam Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-Analysis
Susu Zhou, Devashish Desai, Sam Benjamin, et al.
Southern Medical Journal
|
November 14, 2008
Ortner syndrome in an elderly vasculopath
Madhav C Menon, Sam Benjamin, Manju Paul, et al.
Targeted Oncology
|
December 3, 2025
Can PARP Inhibitors Benefit Patients with Homologous Recombination Repair-Proficient Castration-Resistant Prostate Cancer? A Meta-analysis
Susu Zhou, Devashish Desai, Noriko Kishi, et al.
American Journal of Therapeutics
|
April 29, 2025
A Meta-Analysis Studying the Difference in Response to Trastuzumab-Deruxtecan Based on HER2 Immunohistochemistry Staining in HER2 Low Metastatic Breast Cancer Patients
Prashanth Ashok Kumar, Michael Sandhu, Devashish Desai, et al.
Cancers
|
December 9, 2023
Breast Cancer Treatment: To tARget or Not? That Is the Question
Alexandra Stone, Kevin M Lin, Ghanshyam H Ghelani, et al.
Clinical Genitourinary Cancer
|
June 25, 2026
Long-Term Survival Outcomes of Immune Checkpoint Inhibitor-based Combination Therapies in Favorable-Risk Metastatic Renal Cell Carcinoma: An Updated Pairwise and Network Meta-Analysis
Susu Zhou, Sanjay Rao Gergal Gopalkrishna Rao, Vishw Patel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Anticancer Research
|
September 16, 2016
A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab
Alina Basnet, Nibal Saad, Sam Benjamin
Radiology Case Reports
|
January 31, 2024
Hepatocellular carcinoma metastatic to the pituitary gland without an identifiable primary lesion
Jacquelyn Knapp, Harish Babu, Sam Benjamin, et al.
Cureus
|
August 9, 2020
Mucosal Melanoma: A Rare Entity and Review of the Literature
Raman J Sohal, Sandeep Sohal, Ali Wazir, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-Analysis
Susu Zhou, Devashish Desai, Sam Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-Analysis
Susu Zhou, Devashish Desai, Sam Benjamin, et al.
Southern Medical Journal
|
November 14, 2008
Ortner syndrome in an elderly vasculopath
Madhav C Menon, Sam Benjamin, Manju Paul, et al.
Targeted Oncology
|
December 3, 2025
Can PARP Inhibitors Benefit Patients with Homologous Recombination Repair-Proficient Castration-Resistant Prostate Cancer? A Meta-analysis
Susu Zhou, Devashish Desai, Noriko Kishi, et al.
American Journal of Therapeutics
|
April 29, 2025
A Meta-Analysis Studying the Difference in Response to Trastuzumab-Deruxtecan Based on HER2 Immunohistochemistry Staining in HER2 Low Metastatic Breast Cancer Patients
Prashanth Ashok Kumar, Michael Sandhu, Devashish Desai, et al.
Cancers
|
December 9, 2023
Breast Cancer Treatment: To tARget or Not? That Is the Question
Alexandra Stone, Kevin M Lin, Ghanshyam H Ghelani, et al.
Clinical Genitourinary Cancer
|
June 25, 2026
Long-Term Survival Outcomes of Immune Checkpoint Inhibitor-based Combination Therapies in Favorable-Risk Metastatic Renal Cell Carcinoma: An Updated Pairwise and Network Meta-Analysis
Susu Zhou, Sanjay Rao Gergal Gopalkrishna Rao, Vishw Patel, et al.
Page
of 2